Prospective Evaluation of a Commercially Available Hydrogel Spacer

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

June 29, 2021

Study Completion Date

February 8, 2022

Conditions
Prostate Cancer
Interventions
OTHER

Observation

Assessment of rectal dosimetry change from pre-insertion to post-insertion in subjects with prostate cancer who have undergone radiotherapy with a hydrogel spacer.

Trial Locations (2)

89521

Northern Nevada Radiation Oncology, Reno

95008

Western Radiation Oncology, Campbell

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BioProtect

INDUSTRY